Randomized Trial of Active vs Passive Splinting for Extensor Tendon Injuries in Zones IV to VI (NCT06950268) | Clinical Trial Compass
CompletedNot Applicable
Randomized Trial of Active vs Passive Splinting for Extensor Tendon Injuries in Zones IV to VI
Spain30 participantsStarted 2020-07-01
Plain-language summary
This study compares two methods of post-operative immobilization after surgical repair (tenorrhaphy) of extensor tendons in the fingers. Patients were randomly assigned to receive either a standard plaster splint or an alternative splinting method that allows controlled finger movement (ICAMS). The main goal was to determine which method leads to better recovery in terms of finger mobility, grip strength, pain, and patient comfort.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18 years or older
* Patients from the CHUVI Health Area
* Diagnosed with an acute, single, complete extensor tendon laceration in zones IV, V, or VI of the long fingers
* Treated with primary tenorrhaphy
* Provided signed informed consent
* Agreed to attend follow-up visits and comply with the study protocol
Exclusion Criteria:
* More than one extensor tendon laceration in the same hand
* Injuries involving the thumb
* Tendon injuries with loss of substance
* Associated injuries at the same level (e.g., bone fracture, nerve lesion)
* Patients with cognitive impairment or inability to follow the protocol
* Presence of other injuries or medical conditions that could interfere with assessment
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.